$NUGN
Livento Group Inc

2023 Q4 Form 10-K Financial Statement

#000149315224012301 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $2.000M $2.000M
YoY Change 0.0% 0.0%
Cost Of Revenue $2.941M $2.071M
YoY Change 41.97%
Gross Profit -$934.8K -$105.1K
YoY Change 789.52%
Gross Profit Margin -46.74% -5.25%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.612M $482.3K
YoY Change 1063.41%
Operating Profit -$6.546M -$587.4K
YoY Change 1014.41%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $288.00 $100.3K
YoY Change -99.71%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$6.546M -$487.2K
YoY Change 1243.74% 126.71%
Net Earnings / Revenue -327.31% -24.36%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 812.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $30.63K
Short-Term Investments
Other Short-Term Assets $355.0K
YoY Change 192.28%
Inventory $0.00
Prepaid Expenses
Receivables $682.1K
Other Receivables
Total Short-Term Assets $1.068M
YoY Change 68.01%
LONG-TERM ASSETS
Property, Plant & Equipment $26.82K
YoY Change
Goodwill $0.00
YoY Change
Intangibles $45.14M
YoY Change 254.67%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $45.79M
YoY Change 101.91%
TOTAL ASSETS
Total Short-Term Assets $1.068M
Total Long-Term Assets $45.79M
Total Assets $46.86M
YoY Change 100.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $323.9K
YoY Change 132.16%
Accrued Expenses $85.67K
YoY Change 36.96%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $409.6K
YoY Change -87.39%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $409.6K
Total Long-Term Liabilities
Total Liabilities $3.838M
YoY Change 18.16%
SHAREHOLDERS EQUITY
Retained Earnings -$18.92M
YoY Change 51.94%
Common Stock $22.70K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.02M
YoY Change
Total Liabilities & Shareholders Equity $46.86M
YoY Change 100.98%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income -$6.546M -$487.2K
YoY Change 1243.74% 126.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$433.1K $522.1K
YoY Change -182.97% -30.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.414M -$4.395M
YoY Change -67.82% -58.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.498M -$53.89K
YoY Change -2878.99% -176.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.854M $3.412M
YoY Change -45.68% -66.63%
NET CHANGE
Cash From Operating Activities -$433.1K $522.1K
Cash From Investing Activities -$1.414M -$4.395M
Cash From Financing Activities $1.854M $3.412M
Net Change In Cash $6.475K -$460.0K
YoY Change -101.41% -195.46%
FREE CASH FLOW
Cash From Operating Activities -$433.1K $522.1K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$433.1K $522.1K
YoY Change -182.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2022 NUGN Stock Issued During Period Value Issuance Of Series C Preferred Shares To David Stybr And Their Cancelation
StockIssuedDuringPeriodValueIssuanceOfSeriesCPreferredSharesToDavidStybrAndTheirCancelation
usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022 NUGN Stock Issued During Period Value Cancelation Of Common Shares By Former Director
StockIssuedDuringPeriodValueCancelationOfCommonSharesByFormerDirector
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10004
CY2023 dei City Area Code
CityAreaCode
(980)
CY2023 dei Local Phone Number
LocalPhoneNumber
432-8241
CY2023 dei Security12g Title
Security12gTitle
Common stock, par value $0.0001
CY2023 dei Trading Symbol
TradingSymbol
NUGN
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
14301080 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
812799962 shares
CY2023 dei Auditor Name
AuditorName
OLAYINKA OYEBOLA & CO.
CY2023 dei Auditor Firm
AuditorFirmId
5968
CY2023 dei Auditor Location
AuditorLocation
Lagos, Nigeria
CY2023Q4 us-gaap Cash
Cash
30634 usd
CY2022Q4 us-gaap Cash
Cash
24159 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
682138 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
489910 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
355001 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
121460 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1067773 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
635529 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
654288 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
9952880 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
45137942 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12726847 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
45792230 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
22679728 usd
CY2023Q4 us-gaap Assets
Assets
46860003 usd
CY2022Q4 us-gaap Assets
Assets
23315257 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
323936 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
139530 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
85665 usd
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
62549 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
409602 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
202079 usd
CY2023Q4 NUGN Co Investments
CoInvestments
3428403 usd
CY2022Q4 NUGN Co Investments
CoInvestments
3046017 usd
CY2023Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3428403 usd
CY2022Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3046017 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3838005 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3248096 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
227001268 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
227001268 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
22700 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
22700 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61939774 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32493023 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18917776 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12450797 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
43021998 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20067160 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46860003 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23315257 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2005789 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1966202 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
2940555 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2071289 usd
CY2023 us-gaap Gross Profit
GrossProfit
-934767 usd
CY2022 us-gaap Gross Profit
GrossProfit
-105087 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5396566 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
358231 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
209563 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
120750 usd
CY2023 NUGN Rental Expense
RentalExpense
5544 usd
CY2022 NUGN Rental Expense
RentalExpense
3366 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
5611673 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
482347 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-6546440 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-587434 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
288 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100277 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6546152 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-487158 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20187883 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20187883 usd
CY2022 NUGN Stock Sales Of Series D Preferred Shares
StockSalesOfSeriesDPreferredShares
366435 usd
CY2022 NUGN Stock Cancelation Of Common Shares And Their Transformation To Series C Preferred Shares
StockCancelationOfCommonSharesAndTheirTransformationToSeriesCPreferredShares
0 usd
CY2022 NUGN Stock Sales Of Series C Preferred Shares
StockSalesOfSeriesCPreferredShares
-0 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-487158 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20067160 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20067160 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20067160 usd
CY2023 NUGN Stock Sales Of Series C Preferred Shares
StockSalesOfSeriesCPreferredShares
268 usd
CY2023 NUGN Stock Sales Of Series D Preferred Shares
StockSalesOfSeriesDPreferredShares
15340 usd
CY2023 NUGN Stock Issued During Period Value Transformation Of Preferred Share Class And Transformation To Common Shares
StockIssuedDuringPeriodValueTransformationOfPreferredShareClassAndTransformationToCommonShares
15457 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
29446751 usd
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
11020 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-6573159 usd
CY2023 NUGN Stock Sales Of Series E And F Preferred Shares
StockSalesOfSeriesEAndFPreferredShares
4 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
39159 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
43021998 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6546152 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-487158 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1839634 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1677410 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4079961 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
180758 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
489910 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
105086 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-119370 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
67427 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
121460 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
340314 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
62549 usd
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6113012 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1009219 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-433140 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
522061 usd
CY2023 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
5360 usd
CY2022 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
23521 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408600 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3455000 usd
CY2023 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 usd
CY2022 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
2000000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 usd
CY2022 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 usd
CY2023 NUGN Proceeds From Security Deposits Asset
ProceedsFromSecurityDepositsAsset
0 usd
CY2022 NUGN Proceeds From Security Deposits Asset
ProceedsFromSecurityDepositsAsset
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1413960 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1478521 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1497572 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
366435 usd
CY2023 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0 usd
CY2022 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0 usd
CY2023 NUGN Proceeds From Issuance Of Dividends Paid
ProceedsFromIssuanceOfDividendsPaid
0 usd
CY2022 NUGN Proceeds From Issuance Of Dividends Paid
ProceedsFromIssuanceOfDividendsPaid
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
356003 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
130000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1853575 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
496435 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6475 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-460024 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24159 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
484183 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30634 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24159 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_zbspYOQsshJj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span><span id="xdx_821_zmtvQeeMmRg5">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nugene International, Inc (formerly Bling Marketing) was incorporated in Nevada. On March 24, 2022, Livento Group LLC announced the acquisition of NUGN and confirmed a change in its business model, redirecting its focus to Livento’s three primary sectors: real estate finance &amp; development, artificial intelligence, machine learning technology, and film and television production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Livento Group LLC was acquired by Nugene International Inc, and the transaction was accounted for on a historical cost basis of Nugene International Inc i.e. (Ultimate Parent Basis). The Members capital of Livento Group LLC was recorded in the Additional paid in capital of Nugene International Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Livento Group LLC was incorporated on <span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231_zx2woaYPyTii" title="Entity incorporation date">01/10/2020</span> in Delaware, USA. The business purpose of the company is management and business holding company for real estate and artificial intelligence services. Its focus in real estate is on residential development in Czech Republic and in artificial intelligence development of portfolio software used by asset managers to determine best mix of stocks from selected index.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Control</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March, 2022, Ms. Hoffman sold her Series A Preferred stock in the Company and certain shares of Series C Preferred Stock to Livento Group, LLC, a limited liability company formed by Mr. Stybr in 2020, for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220331__20220331__srt--TitleOfIndividualAxis__custom--MsHoffmanMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAAndCertainSeriesCPreferredStockMember_zVBrDwghGmw7" title="Value of shares sold">200,000</span>. Also in March 2022, Mr. Stybr, agreed to contribute Livento Group, LLC to the Company in exchange for a transfer to him of the Series A Preferred Stock which gave Mr. Stybr voting control of the Company. Mr. Stybr was the sole member and manager of Livento Group LLC prior to such transfer, and has over $<span id="xdx_90D_eus-gaap--InvestmentOwnedAtCost_iI_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MrStybrMember__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zH8dAqJwArn7" title="Investment owned">19,000,000</span> invested in the entity. The Series C Preferred Stock purchased by Livento Group, LLC was cancelled shortly after it was acquired by Livento. Following such cancellation, Livento Group LLC, and Mr. Stybr, owned/controlled <span id="xdx_90C_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MrStybrMember__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zfOtBEVZFkgf" title="Investment owned shares">100</span> shares of Series A Preferred Stock of the Company, which has <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MrStybrMember__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zAsjJJoFMY34" title="Voting rights percentage">51</span>% voting rights. As a result of these transactions our current operations are the operations of Livento Group, LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company’s registered office is located in the State of Delaware, 19 Holly Cove Ln., City of Dover, Kent, 19901, Head office on 17 State Street, Suite 4000, New York, NY, 10004.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s founder and director is David Stybr</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-01-10
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zVimtfamwkY7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zAA0LPyq9CR5">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z8vn5E2fOd7h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zJkTloYqAIK8">Concentrations of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes the Company is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24159 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30634 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 NUGN Asset Acquisition Percentage Of Shares Transferred
AssetAcquisitionPercentageOfSharesTransferred
1 pure
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
7171659 usd
CY2023 us-gaap Revenues
Revenues
2000000 usd
CY2021 us-gaap Revenues
Revenues
2000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32657258 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5032230 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
714589 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1677410 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1824076 usd

Files In Submission

Name View Source Status
0001493152-24-012301-index-headers.html Edgar Link pending
0001493152-24-012301-index.html Edgar Link pending
0001493152-24-012301.txt Edgar Link pending
0001493152-24-012301-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nugn-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nugn-20231231_cal.xml Edgar Link unprocessable
nugn-20231231_def.xml Edgar Link unprocessable
nugn-20231231_lab.xml Edgar Link unprocessable
nugn-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
Show.js Edgar Link pending